The groundbreaking treatment of the medication represents a major advance in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets multiple pathways – GLP-1 and GIP – https://tirzepatidepeptide502992.bloggerchest.com/42151562/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment